No Data
No Data
Shanghai Haishun New Pharmaceutical Packaging (300501.SZ): Repurchased 2.43% of its shares.
On July 1st, Gelunhui reported that Shanghai Haishun New Pharmaceutical Packaging (stock code 300501.SZ) had repurchased a total of 4,705,600 shares of the company through the Shenzhen Stock Exchange stock trading system by means of centralized bidding trading, accounting for approximately 2.43% of the total share capital of the company at the highest fill price of 12.84 yuan/share and the lowest fill price of 10.39 yuan/share, with a total transaction amount of RMB 54,863,266.00 (excluding transaction fees), as of June 30, 2024. This repurchase complies with the company's repurchase plan and relevant laws and regulations.
Shanghai Haishun New Pharmaceutical Packaging (300501.SZ): Aluminum-plastic film is mainly used for soft-pack batteries, currently mainly supplying 3C and energy storage customers.
On June 19, 2024, Shanghai Haishun New Pharmaceutical Packaging (300501.SZ) accepted a specific investigation and was asked about "which types of batteries the company's aluminum-plastic film products are suitable for and which battery customers they supply to?" The company replied that aluminum-plastic film is mainly used for soft-pack batteries, which are mainly used in the fields of 3C, power, and energy storage. The production of batteries used in the 3C category is relatively scattered, and the company currently mainly supplies to 3C and energy storage customers.
Shanghai Haishun New Pharmaceutical Packaging (300501.SZ): Part of the production capacity built with its own funds in Nanxun has been put into operation. The recent private placement projects have been in trial production for the past few months.
On June 19, 2024, shanghai haishun new pharmaceutical packaging (300501.SZ) accepted specific object research. When asked about the production time of the "Nanxun Project", the company responded that some of the self-funded production capacity of Nanxun has been put into operation, and the recent fixed-increment project has been in trial production, and production capacity will be gradually released in the second half of the year.
Shanghai Haishun New Pharmaceutical Packaging (300501.SZ): Currently, the total production capacity is about 40,000 tons, with a production volume of about 33,000 tons.
On June 19th, 2024, Shanghai Haishun New Pharmaceutical Packaging(300501.SZ) accepted a specific object investigation, and in response to the question "What is the current production capacity and output of the company?", the company replied that the total production capacity is currently about 40,000 tons, and the output is about 33,000 tons. It is expected that there will be a significant increase in production capacity after the gradual production of projects financed by the private placement and convertible bonds this year.
Shanghai Haishun New Pharmaceutical Packaging (300501.SZ) has spent about 50 million yuan repurchasing 2.19% of its shares.
Shanghai Haishun New Pharmaceutical Packaging (300501.SZ) announced that as of June 6, 2024, the company has passed the Shenzhen Stock Exchange's...
Haishun New Materials (300501.SZ) plans to pay 1.5 yuan for 10 shares to be deducted from interest on May 28
Haishun New Materials (300501.SZ) announced that the company's 2023 equity distribution plan: to all shareholders every 10...
No Data